Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07816744) titled 'Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Axel Brandes
Condition:
Atrial Fibrillation (AF)
Obesity & Overweight
Intervention:
Other: Structured weight loss program including behavioral support and optional meal re-placement or pharmacotherapy with Glucagon-like peptide-1 receptor agonists (GLP1-RA)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, ...